| |
|
|
|
Leap Therapeutics Inc.  
|
|
1.94 0.03 (0.02%) |
09-18 16:00 |
|
Open: |
1.93 |
Pre close: |
1.91 |
Target:
|
2.46
|
|
High: |
2.04 |
Low: |
1.91 |
Resistance:
|
2.11
2.46
|
|
Volume: |
936,216 |
Market Cap: |
116M |
Support:
|
1.84
1.68
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.93
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
1.84 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
2.09  |
Stochastic Oscillator |
%K(14,3):
|
55.81 |
|
MA(250): |
1.74 |
%D(3): |
55.81 |
|
Average Volume(K) |
3-Month: |
78768
|
52-Week |
High:
|
3.18 |
|
10-Days: |
55597 |
Low: |
0.57 |
|
RSI |
RSI(14):
|
53.40 |
Change(%): |
27.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.206 |
Return on Equity (ttm) |
-84.0 |
Shares Out. (M) |
59.42 |
|
EPS Est. Current Year |
-3.160 |
Return on Assets (ttm) |
-42.7 |
Shares Float (M) |
33.29 |
|
EPS Est. Next Year |
-3.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.06 |
|
EPS Est. Next Quarter |
-0.630 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
48.18 |
|
Forward EPS |
-1.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
816 |
|
Book Value (p.s.) |
1.000 |
EBITDA (p.s.) |
-0.504 |
P/E |
-1.61 |
|
Sales Per Share |
0.013 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.94 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.23 |
P/S |
153.70 |
|
Operating Margin |
-3994.80 |
Levered Free Cash Flow
(M) |
-16.37 |
P/CF |
-4.39 |
|
|
|
|
|
|
